A+ | A | A- | Skip to main content |

Sensex

Nifty

USDINR

GBPINR

EURINR

Thursday, 11 June 2026 03:39 PM	Asian-Paints2685.00	Hind-Unilever2138.95	ITC282.30	Trent2721.00	Larsen-and-Toubro3859.45	M-and-M3001.20	Reliance-Industries1262.60	Tata-Steel198.00	Titan-Company4033.75	SBI1000.65	Bharat-Electron402.35	Kotak-Mah-Bank392.30	Infosys1114.00	Bajaj-Finance870.30	Sun-PharmaInds1798.80	HDFC-Bank744.60	TCS2137.00	ICICI-Bank1314.50	Power-Grid-Corpn286.65	Maruti-Suzuki13117.00	Axis-Bank1317.45	HCL-Technologies1110.00	NTPC352.00	Bharti-Airtel1786.00	Tech-Mahindra1468.55	Adani-Ports1787.30	UltraTech-Cem10854.70	Bajaj-Finserv1649.00	Interglobe-Aviat4479.30	Eternal236.00
15 mins delay SENSEX 73,832.55 [-150.63]	-29.85 -1.10%	-30.35 -1.40%	-1.45 -0.51%	-31.80 -1.16%	-57.90 -1.48%	49.30 1.67%	3.05 0.24%	-1.05 -0.53%	-5.60 -0.14%	-2.65 -0.26%	-6.10 -1.49%	4.30 1.11%	-31.05 -2.71%	-13.75 -1.56%	11.70 0.65%	-2.40 -0.32%	-16.90 -0.78%	21.25 1.64%	-0.60 -0.21%	40.95 0.31%	2.85 0.22%	-22.05 -1.95%	0.40 0.11%	10.60 0.60%	-9.95 -0.67%	-34.75 -1.91%	-11.45 -0.11%	-15.05 -0.90%	-44.25 -0.98%	-3.60 -1.50%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Cipla receives VAI status for Goa plant from USFDA

11-Jun-26 14:27Hrs IST

The classification pertains to the routine current Good Manufacturing Practices (cGMP) inspection and a Pre-Approval Inspection (PAI) conducted by the USFDA at the company's manufacturing facility in Verna, Goa, India between 6th to 17th April 2026.

Cipla is a global pharmaceutical company with operations across India, South Africa, North America and other regulated and emerging markets. The company focuses on complex generics and therapies including respiratory, anti-retroviral, urology, cardiology, anti-infective and CNS segments. Cipla operates 46 manufacturing facilities globally, producing more than 1,500 products across over 80 markets.

The drug major's consolidated net profit stood at Rs 554.64 crore in Q4 FY26, down 54.61% from Rs 1,221.84 crore in Q4 FY25. Revenue from operations declined 2.02% YoY to Rs 6,464.26 crore in Q4 FY26 from Rs 6,597.72 crore in the year-ago period.

The counter rose 0.61% to Rs 1384.65 on the BSE.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise